Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-24-041809
Filing Date
2024-10-21
Accepted
2024-10-21 17:20:15
Documents
62
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 1247890
2 ex21-1.htm EX-21.1 3564
3 ex31-1.htm EX-31.1 18723
4 ex31-2.htm EX-31.2 18933
5 ex32-1.htm EX-32.1 9050
6 audit_001.jpg GRAPHIC 14398
7 audit_002.jpg GRAPHIC 6567
8 audit_003.jpg GRAPHIC 29566
9 audit_004.jpg GRAPHIC 7570
10 audit_005.jpg GRAPHIC 3072
  Complete submission text file 0001493152-24-041809.txt   5183084

Data Files

Seq Description Document Type Size
11 XBRL SCHEMA FILE vicp-20231231.xsd EX-101.SCH 34320
12 XBRL CALCULATION FILE vicp-20231231_cal.xml EX-101.CAL 39119
13 XBRL DEFINITION FILE vicp-20231231_def.xml EX-101.DEF 157863
14 XBRL LABEL FILE vicp-20231231_lab.xml EX-101.LAB 352293
15 XBRL PRESENTATION FILE vicp-20231231_pre.xml EX-101.PRE 279321
64 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 532999
Mailing Address 1735 BUFORD HIGHWAY STE. 215-113 CUMMING GA 30041
Business Address 1735 BUFORD HIGHWAY STE. 215-113 CUMMING GA 30041 470-514-4013
Vicapsys Life Sciences, Inc. (Filer) CIK: 0001468639 (see all company filings)

EIN.: 621153426 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-56145 | Film No.: 241384207
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)